Silo Pharma, Inc., listed on Nasdaq under the ticker SILO and active both in early-stage biopharmaceutical development and digital asset treasury management, has disclosed the selection of the Alphaledger/Simplify Target 12% Distribution Fund LLC as a central pillar in its real-world asset (RWA) investment strategy built on the Solana blockchain. The company framed the allocation as consistent with its approach to treasury diversification and progressive integration of blockchains into corporate financial structure.
Alphaledger, the firm behind the T12 Fund, is described as a provider of blockchain infrastructure tailored to regulated financial assets. Its core offerings cover origination, trading, settlement, and autonomous clearing technology. The company operates a tokenization platform known as Vulcan Forge that is built to automate and synchronize the lifecycle of securities using blockchain-based rails, with the goal of eliminating frictions and latency in multi-party financial workflows.
Fund Targets High-Frequency Income From Tokenized Fixed Income Mix
The Alphaledger T12 Fund is characterized as a digital-native investment product granting institutional access to tokenized RWAs on public blockchains. It is structured to pursue high monthly income by allocating to an assortment of alternative, income-bearing strategies. Because the fund operates on Solana, its investors interact with tokenized instruments through low-latency, low-fee transactions while retaining on-chain verifiability. Its portfolio approach blends high-yield and short-duration fixed income with hedged credit and systematically managed option overlays. Fund materials describe the mix as engineered to generate yield while attempting to mitigate overall risk exposure.
Silo Pharma reiterated in its corporate profile that its therapeutic research pipeline targets stress-related psychiatric disorders, chronic pain, and central nervous system conditions, while its treasury strategy is being positioned as a parallel strategic pillar intended to capture optionality in digitally native capital markets.
Management Frames Allocation as a Strategic Bridge to DeFi Infrastructure
Silo’s chief executive, Eric Weisblum, conveyed that the investment is being interpreted internally not only as a mechanism to diversify treasury holdings but also as a deliberate step toward deeper exposure to decentralized financial infrastructure. He stated that the company’s digital asset strategy aims to capture structural value emerging across multi-chain architectures and suggested that the T12 Fund serves as a pragmatic on-chain conduit between traditional financial yield products and programmable digital assets. According to his view, the arrangement is expected to preserve access to yield-producing tokenized RWAs while seeking to dampen aggregate portfolio volatility.
Alphaledger co-founder and chief executive Manish Dutta remarked that Silo’s participation could be read as evidence that institutional counterparties are beginning to embed tokenized RWAs within regulated investment frameworks. He asserted that Alphaledger’s mission is to redesign investing through asset tokenization using blockchain and to reassign financial control directly to investors. He added that the firm considers Silo’s decision a validation of the T12 Fund’s role inside institutional digital asset strategies.
Move Mirrors Institutional Drift Toward Tokenized Balance Sheet Assets
Market analysts observed that Silo’s allocation fits within a broader institutional pattern in which corporations and funds are starting to place tokenized RWAs on the balance sheet in search of yield, transparency, and programmable compliance. By leveraging the Alphaledger T12 Fund architecture and Solana’s high-throughput network, Silo acquires exposure to on-chain financial products framed as transparent, compliant, and operationally efficient. The allocation is also being interpreted as consistent with Silo’s attempt to build a cohesive interface between its biopharmaceutical business, a growing crypto treasury practice, and fintech-aligned capital strategies that embed tokenization into corporate finance.
